I-Flow predicts growth phase, PLC prepares for "pivotal period"
This article was originally published in Clinica
Executive Summary
Curis, the result of a three-way merger between Creative BioMolecules, Ontogeny and Reprogenesis in July 2000, has completed its first fiscal year. The Cambridge, Massachusetts company says that, because of the merger and associated charges, a comparison of previous years' business with that of the period under review does not provide a true reflection of current performance.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.